Lyos Therapeutics
CompanyMentioned in 1 video
A spin-off from MAPS, this pharmaceutical company has been conducting phase three clinical trials for MDMA-assisted therapy for PTSD.
A spin-off from MAPS, this pharmaceutical company has been conducting phase three clinical trials for MDMA-assisted therapy for PTSD.